|
市場調査レポート
商品コード
1403669
ポリコサノールの世界市場規模、シェア、産業動向分析レポート:原料別、用途別、地域別の展望と予測、2023年~2030年Global Policosanol Market Size, Share & Industry Trends Analysis Report By Source, By Application (Pharmaceutical Drugs, Dietary Supplements, Personal Care & Cosmetics, and Animal Feed), By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
ポリコサノールの世界市場規模、シェア、産業動向分析レポート:原料別、用途別、地域別の展望と予測、2023年~2030年 |
出版日: 2023年12月28日
発行: KBV Research
ページ情報: 英文 265 Pages
納期: 即納可能
![]() |
ポリコサノール市場規模は、予測期間中にCAGR 6.4%で成長し、2030年には4億7,570万米ドルに達すると予測されます。2022年の市場規模は272.02トンで、成長率は6.1%となっています(2019-2022年)。
しかし、健康保険はスタチンを含む処方薬に適用されることが多く、それによって患者がこれらの治療薬にアクセスしやすくなり、購入しやすくなっています。栄養補助食品としてのポリコサノールは、同じレベルの保険適用を享受できない可能性があり、個人によってはその手頃な価格に影響を与える可能性があります。さらに、スタチンの有効性と安全性は確立されているため、医師はスタチンの処方に慣れています。スタチン製剤に慣れ親しみ、臨床での実績があることから、多くのヘルスケア・プロバイダーがコレステロールを管理する際にスタチン製剤を好んで選択しています。このような要因が市場の需要を制限する可能性があります。
供給源の展望
供給源に基づき、市場はサトウキビ、小麦胚芽、蜜蝋、その他に区分されます。2022年には、小麦胚芽セグメントが市場で大きな収益シェアを獲得しました。小麦胚芽の栄養プロファイルは、ポリコサノールの潜在的な健康上の利点を補完します。この2つの栄養学的利点は、小麦胚芽由来のポリコサノールサプリメントの魅力を高めることができます。ポリコサノールと小麦胚芽に含まれる他の生物活性化合物を組み合わせることで、相乗効果が得られる可能性があります。研究者やメーカーは、ポリコサノールと小麦胚芽に含まれる他の成分との相乗効果を活用し、全体的な健康効果を高める製剤を探求する可能性があります。したがって、この分野は今後数年間で急速に成長すると思われます。
用途別展望
用途別では、市場は栄養補助食品、医薬品、パーソナルケア&化粧品、動物飼料に分けられます。2022年には、パーソナルケア・化粧品分野が市場で大きな収益シェアを占めました。ポリコサノールは、その潜在的な抗炎症作用について研究されています。スキンケアでは、炎症に対処することは、赤みや炎症などの症状にとって極めて重要です。抗炎症特性を持つ化粧品製剤は注目されており、ポリコサノールはそのような用途に探索される可能性があります。化粧品業界では、天然成分や植物由来成分の需要が高まっています。天然ワックス由来のポリコサノールは、植物や植物由来の製剤を求める動向に合致しています。これらの側面は、このセグメントの拡大に役立つであろう。
地域別展望
地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAに区分されます。2022年には、アジア太平洋セグメントが市場で最も高い収益シェアを獲得しました。アジア太平洋地域の多くの国では、高齢化を含む人口動態の変化が起きています。高齢化に伴い、心臓の健康やコレステロールの管理に対する懸念が顕著になり、ポリコサノールのようなサプリメントに対する需要が高まる可能性があります。その結果、このセグメントは今後数年間で急成長すると思われます。
The Global Policosanol Market size is expected to reach $475.7 million by 2030, rising at a market growth of 6.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 272.02 Tonnes, experiencing a growth of 6.1% (2019-2022).
The growing awareness of the importance of heart health and overall well-being has led consumers in North America to seek natural solutions including Policosanol. Consequently, the North America region would account for nearly 27% of the total market share by 2030. Policosanol, known for its potential cholesterol-lowering effects, aligns with the trend of health-conscious individuals looking for dietary supplements. These factors will help in the expansion of the segment. Some of the factors impacting the market are the increase in the aging population worldwide, regulatory approvals and endorsements and competition from prescription medications.
As individuals grow older, they frequently develop a heightened awareness of the potential hazards linked to conditions such as elevated cholesterol and become more health conscious. Furthermore, the desire for an improved quality of life and increased longevity may drive seniors to explore various health-enhancing strategies, including dietary supplements. Cholesterol management is a crucial aspect of maintaining overall health and well-being. Recognizing the demographic shift and the associated health concerns, the supplement industry may respond by innovating and introducing products specifically targeted at cholesterol management in the aging population. These factors are expected to boost the demand in the market. Additionally, Regulatory bodies often establish standards for health claims and labeling of dietary supplements. Clear regulations on what health claims can be made about polycosanol and accurate and transparent labeling provide consumers with reliable information and contribute to market trust. Furthermore, regulatory bodies often require scientific evidence to substantiate health claims made by dietary supplements. Positive scientific studies supporting the cholesterol-lowering effects of polycosanol can strengthen its position in the market. As a result, these aspects will lead to increased demand in the market.
However, health insurance frequently provides coverage for prescription medications, including statins, thereby enhancing patients' accessibility and affordability of these treatments. Policosanol, as a dietary supplement, may not enjoy the same level of insurance coverage, potentially impacting its affordability for some individuals. Furthermore, physicians are more accustomed to prescribing statins due to their well-established effectiveness and safety profile. Their familiarity with statins and their proven track record in clinical practice makes them a preferred choice for many healthcare providers when managing cholesterol. These factors can limit the demand in the market.
Source Outlook
Based on source, the market is segmented into sugarcane, wheat germ, beeswax, and others. In 2022, the wheat germ segment garnered a significant revenue share in the market. The nutritional profile of wheat germ complements the potential health benefits of policosanol. This dual nutritional advantage can enhance the appeal of wheat germ-derived policosanol supplements. Combining policosanol with other bioactive compounds in wheat germ may offer synergistic effects. Researchers and manufacturers may explore formulations that leverage the synergies between policosanol and other components in wheat germ to enhance the overall health benefits. Therefore, the segment will grow rapidly in the coming years.
Application Outlook
On the basis of application, the market is divided into dietary supplements, pharmaceutical drugs, personal care & cosmetics, and animal feed. In 2022, the personal care and cosmetics segment witnessed a substantial revenue share in the market. Policosanol has been studied for its potential anti-inflammatory effects. In skin care, addressing inflammation is crucial for conditions such as redness and irritation. Cosmetic formulations with anti-inflammatory properties are of interest, and policosanol may be explored for such applications. The cosmetics industry is experiencing a growing demand for natural and plant-based ingredients. Policosanol derived from natural waxes aligns with the trend toward botanical and plant-based formulations. These aspects will help in the expansion of the segment.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific segment acquired the highest revenue share in the market. Many countries in the Asia Pacific region are experiencing demographic shifts, including an aging population. As individuals age, heart health and cholesterol management concerns become more prominent, potentially driving the demand for supplements such as policosanol. As a result, the segment will grow rapidly in the upcoming years.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sabinsa corporation, Sunpure Extracts Private Limited, SHREEJI PHARMA International, Huzhou Shengtao Biotechnology Co., Ltd., Botanic Healthcare Group, Bioriginal Food & Science Corp (Cooke, Inc.), NOW Health Group, Inc. and India Glycols Limited
Market Segments covered in the Report:
By Source (Volume, Tonnes, USD Million, 2019-2030)
By Application (Volume, Tonnes, USD Million, 2019-2030)
By Geography (Volume, Tonnes, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research